welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
my stoma bag storyLeanne Hammond My story; life isn't s...
Genomic Era Diagnosis and Management of Hereditary and Sporadic Colon CancerThe morbidity and mortality attributable...
Targeting Wnt Signaling in Colorectal Cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanis...The evolutionarily conserved Wnt signali...
Outcome Based on Management for Duodenal Adenomas: Sporadic versus Familial DiseaseINTRODUCTION : Management and outcomes f...
Efficacy and Safety of Eflornithine (CPP-1X)/Sulindac Combination Therapy Versus each as Monotherapy in Patients wit...Molecular studies suggest inhibition of ...
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)A study to evaluate rofecoxib in the tre...
Hereditary Colorectal Cancerhttps://www.fapvoice.com/wp-content/uplo...